BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 38102125)

  • 1. New ruthenium-xanthoxylin complex eliminates colorectal cancer stem cells by targeting the heat shock protein 90 chaperone.
    Santos LS; Silva VR; de Castro MVL; Dias RB; Valverde LF; Rocha CAG; Soares MBP; Quadros CA; Dos Santos ER; Oliveira RMM; Carlos RM; Nogueira PCL; Bezerra DP
    Cell Death Dis; 2023 Dec; 14(12):832. PubMed ID: 38102125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel ruthenium complex with 5-fluorouracil suppresses colorectal cancer stem cells by inhibiting Akt/mTOR signaling.
    Silva VR; Santos LS; de Castro MVL; Dias RB; Valverde LF; Rocha CAG; Soares MBP; Quadros CA; Correa RS; Batista AA; Bezerra DP
    Cell Death Discov; 2023 Dec; 9(1):460. PubMed ID: 38104089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ponicidin inhibits pro-inflammatory cytokine TNF-α-induced epithelial-mesenchymal transition and metastasis of colorectal cancer cells via suppressing the AKT/GSK-3β/Snail pathway.
    Zhang Z; Xu J; Liu B; Chen F; Li J; Liu Y; Zhu J; Shen C
    Inflammopharmacology; 2019 Jun; 27(3):627-638. PubMed ID: 30244296
    [TBL] [Abstract][Full Text] [Related]  

  • 4. PI3K/Akt/GSK-3β signal pathway is involved in P2X7 receptor-induced proliferation and EMT of colorectal cancer cells.
    Zhang WJ; Luo C; Huang C; Pu FQ; Zhu JF; Zhu ZM
    Eur J Pharmacol; 2021 May; 899():174041. PubMed ID: 33737010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CHIP functions as an oncogene by promoting colorectal cancer metastasis via activation of MAPK and AKT signaling and suppression of E-cadherin.
    Xu J; Zhou J; Dai H; Liu F; Li W; Wang W; Guo F
    J Transl Med; 2018 Jun; 16(1):169. PubMed ID: 29921293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Isobavachalcone isolated from
    Li Y; Qin X; Li P; Zhang H; Lin T; Miao Z; Ma S
    Drug Des Devel Ther; 2019; 13():1449-1460. PubMed ID: 31118579
    [No Abstract]   [Full Text] [Related]  

  • 7. Osteopontin Promotes Colorectal Cancer Cell Invasion and the Stem Cell-Like Properties through the PI3K-AKT-GSK/3β-β/Catenin Pathway.
    Cheng Y; Wen G; Sun Y; Shen Y; Zeng Y; Du M; Zhu G; Wang G; Meng X
    Med Sci Monit; 2019 Apr; 25():3014-3025. PubMed ID: 31017126
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heat shock protein 90 promotes epithelial to mesenchymal transition, invasion, and migration in colorectal cancer.
    Nagaraju GP; Long TE; Park W; Landry JC; Taliaferro-Smith L; Farris AB; Diaz R; El-Rayes BF
    Mol Carcinog; 2015 Oct; 54(10):1147-58. PubMed ID: 24861206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gilteritinib induces PUMA-dependent apoptotic cell death via AKT/GSK-3β/NF-κB pathway in colorectal cancer cells.
    Li L; Lin L; Li M; Li W
    J Cell Mol Med; 2020 Feb; 24(3):2308-2318. PubMed ID: 31881122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PIK3CD induces cell growth and invasion by activating AKT/GSK-3β/β-catenin signaling in colorectal cancer.
    Chen JS; Huang JQ; Luo B; Dong SH; Wang RC; Jiang ZK; Xie YK; Yi W; Wen GM; Zhong JF
    Cancer Sci; 2019 Mar; 110(3):997-1011. PubMed ID: 30618098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HSP90 inhibition downregulates thymidylate synthase and sensitizes colorectal cancer cell lines to the effect of 5FU-based chemotherapy.
    Nagaraju GP; Alese OB; Landry J; Diaz R; El-Rayes BF
    Oncotarget; 2014 Oct; 5(20):9980-91. PubMed ID: 25296971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gankyrin sustains PI3K/GSK-3β/β-catenin signal activation and promotes colorectal cancer aggressiveness and progression.
    He F; Chen H; Yang P; Wu Q; Zhang T; Wang C; Wei J; Chen Z; Hu H; Li W; Cao J
    Oncotarget; 2016 Dec; 7(49):81156-81171. PubMed ID: 27835604
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MsrB1 Promotes Proliferation and Invasion of Colorectal Cancer Cells via GSK-3β/β-catenin Signaling Axis.
    Chen XY; Yang SY; Ruan XJ; Ding HY; Wang NX; Liu F; Li JC; Li Y
    Cell Transplant; 2021; 30():9636897211053203. PubMed ID: 34719306
    [TBL] [Abstract][Full Text] [Related]  

  • 14. AHA1 regulates cell migration and invasion via the EMT pathway in colorectal adenocarcinomas.
    Kim D; Moon JW; Min DH; Ko ES; Ahn B; Kim ES; Lee JY
    Sci Rep; 2021 Oct; 11(1):19946. PubMed ID: 34620942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combining trail with PI3 kinase or HSP90 inhibitors enhances apoptosis in colorectal cancer cells via suppression of survival signaling.
    Saturno G; Valenti M; De Haven Brandon A; Thomas GV; Eccles S; Clarke PA; Workman P
    Oncotarget; 2013 Aug; 4(8):1185-98. PubMed ID: 23852390
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HSP90-dependent PUS7 overexpression facilitates the metastasis of colorectal cancer cells by regulating LASP1 abundance.
    Song D; Guo M; Xu S; Song X; Bai B; Li Z; Chen J; An Y; Nie Y; Wu K; Wang S; Zhao Q
    J Exp Clin Cancer Res; 2021 May; 40(1):170. PubMed ID: 33990203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibitor of DNA binding 2 knockdown inhibits the growth and liver metastasis of colorectal cancer.
    Liu F; Chen S; Yu Y; Huang C; Chen H; Wang L; Zhang W; Wu J; Ye Y
    Gene; 2022 Apr; 819():146240. PubMed ID: 35114275
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atractylenolide I inhibits colorectal cancer cell proliferation by affecting metabolism and stemness via AKT/mTOR signaling.
    Wang K; Huang W; Sang X; Wu X; Shan Q; Tang D; Xu X; Cao G
    Phytomedicine; 2020 Mar; 68():153191. PubMed ID: 32135457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CCL21 Facilitates Chemoresistance and Cancer Stem Cell-Like Properties of Colorectal Cancer Cells through AKT/GSK-3β/Snail Signals.
    Lu LL; Chen XH; Zhang G; Liu ZC; Wu N; Wang H; Qi YF; Wang HS; Cai SH; Du J
    Oxid Med Cell Longev; 2016; 2016():5874127. PubMed ID: 27057280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual mTOR/PI3K inhibitor NVP‑BEZ235 arrests colorectal cancer cell growth and displays differential inhibition of 4E‑BP1.
    Alqurashi N; Hashimi SM; Alowaidi F; Ivanovski S; Wei MQ
    Oncol Rep; 2018 Aug; 40(2):1083-1092. PubMed ID: 29845289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.